David Holtz
Director/Board Member at DYNATRONICS CORPORATION
Net worth: 15 507 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Stuart Essig | M | 62 | 27 years | |
| Brian Baker | M | 57 | 6 years | |
| Brian Larkin | M | 55 | 24 years | |
| Richard Caruso | M | 80 |
Provco Ventures
 Provco Ventures Investment ManagersFinance Provco Ventures (Provco Ventures) is a venture capital firm founded in 1978 by Richard E. Caruso. The firm is headquartered in Villanova, Pennsylvania. | 46 years |
| Erin Enright | F | 63 | 9 years | |
| Jeffrey Mosebrook | M | 47 | 18 years | |
| Gabe Ellwein | M | - | 1 years | |
| Sarah Rome-Mealman | F | - | 4 years | |
| Andrew Hulett | M | 50 | - | |
| Jerry N. Holtz | M | - |
Provco Ventures
Provco Ventures Investment ManagersFinance Provco Ventures (Provco Ventures) is a venture capital firm founded in 1978 by Richard E. Caruso. The firm is headquartered in Villanova, Pennsylvania. | 31 years |
| R. Ward | M | 68 | 11 years | |
| Christian Schade | M | 63 | 18 years | |
| Edward Staten | M | - | 5 years | |
| Andrea Caruso | M | - | 18 years | |
| Gary R. DiLella | M | - |
Provco Ventures
Provco Ventures Investment ManagersFinance Provco Ventures (Provco Ventures) is a venture capital firm founded in 1978 by Richard E. Caruso. The firm is headquartered in Villanova, Pennsylvania. | - |
| Michael Withers | M | 55 | 2 years | |
| W. Kent Silvers | M | - |
Provco Ventures
Provco Ventures Investment ManagersFinance Provco Ventures (Provco Ventures) is a venture capital firm founded in 1978 by Richard E. Caruso. The firm is headquartered in Villanova, Pennsylvania. | 29 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| John Krier | M | 47 | 3 years | |
| Kelvyn H. Cullimore | M | 68 | 36 years | |
| James Norman Ogilvie | M | 38 | 5 years | |
| John Bostjancic | M | 53 | - | |
| Richard D. Gorelick | M | 63 | 18 years | |
| Gerard S. Carlozzi | M | 68 | 8 years | |
| David Alma Wirthlin | M | 63 | 4 years | |
| John Henneman | M | 62 | 16 years | |
| Skyler Black | M | 41 | 4 years | |
| Neal Moszkowski | M | 58 | 14 years | |
| Larry K. Beardall | M | 68 | 30 years | |
| T. Robert Perrett | M | - | 7 years | |
| Cynthia L. McHenry | F | - | - | |
| Christopher von Jako | M | 53 | 1 years | |
| Nora Brennan | F | 55 | 12 years | |
| Jennifer Keeler | F | 54 | 2 years | |
| Carol L. Amelio | F | 62 |
NUCRYST Pharmaceuticals Corp.
 NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 4 years |
| Thomas E. Gardner | M | 76 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 2 years |
| Deborah A. Leonetti | F | 68 | - | |
| George Murray | M | - | - | |
| Howard L. Edwards | M | 92 | 18 years | |
| Scott Klosterman | M | 66 | 8 years | |
| Anne VanLent | F | 76 | 16 years | |
| Richard J. Linder | M | 54 | - | |
| Jason C. Anderson | M | - | - | |
| William Weber | M | - | - | |
| Norman Roegner | M | 49 | 2 years | |
| David Poorvin | M | 76 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 4 years |
| Michael J. Shoup | M | 63 | 1 years | |
| Daryl Connell | M | 52 | 2 years | |
| Maureen B. Bellantoni | F | 74 | 1 years | |
| Neil Carragher | M | 85 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 5 years |
| Thomas Jeff Gephart | M | - | 2 years | |
| Tyler Oglesby | M | - | 4 years | |
| Simon J. Archibald | M | - | 17 years | |
| Maria Platsis | F | - | - | |
| Edward Gaj | M | 67 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 3 years |
| Karen Payne | F | - |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | - |
| Richard W. Zahn | M | 73 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 5 years |
| David Wills | M | - |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | - |
| G. A. Fitch | M | - |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 1 years |
| Robert D. Paltridge | M | 66 | - | |
| Jerry E. Corbin | M | 64 | - | |
| Barry Mark Heck | M | 61 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 13 years |
| Todd Simpson | M | 63 | - | |
| Rob B. Rogers | M | - | - | |
| Roger G. H. Downer | M | 81 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 5 years |
| David C. McDowell | M | 68 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 4 years |
| Kevin Breeden | M | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 66 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David Holtz
- Personal Network
